Emerging Ionizing and Non-Ionizing Radiation for Treatment of Musculoskeletal Disorders and Malignancies
ABSTRACT Bone and soft‑tissue sarcoma constitute more than 20% of pediatric solid malignant cancers and almost 1% of adult solid malignant cancer. Musculoskeletal (MSK) disorders are the heterogeneous group of mesenchymal malignancies. Early diagnosis of these has a substantial effect on optimal treatment and quality of life of these patients. New applications and techniques have…